Astrocytic LCN2 drives uremic pruritus and morphine-induced pruritus via the GRP/GRPR pathway
- PMID: 40382493
- DOI: 10.1007/s10157-025-02697-6
Astrocytic LCN2 drives uremic pruritus and morphine-induced pruritus via the GRP/GRPR pathway
Abstract
Background: Uremic pruritus (UP) is a distressing condition in hemodialysis patients with unclear mechanisms. This study investigates the role of LCN2 in pruritus, focusing on its interaction with GRP/GRPR signaling and astrocyte activation.
Methods: Clinical skin biopsy samples from CKD patients with and without UP were analyzed for LCN2 expression. A chronic renal failure mouse model (UP model) was established through surgical kidney ablation, while a morphine-induced itch model was generated via intrathecal morphine injection. LCN2 knockout (LCN2-/-) mice were used to evaluate its functional role in itch modulation. Scratching behavior was recorded, and Western blot, qRT-PCR, immunohistochemistry, immunofluorescence, and ELISA were performed to assess LCN2 expression, GRP/GRPR signaling, and inflammatory cytokines in the spinal cord. Additionally, RC-3095 (a GRPR inhibitor) and GRP were administered to evaluate their effects on pruritus.
Results: LCN2 expression was elevated in CKD patients with UP and positively correlated with itch severity. Similarly, UP model mice showed increased spinal LCN2 levels, while LCN2 deficiency (LCN2-/- mice) reduced scratching behavior. Mechanistically, LCN2 promoted pruritus by enhancing GRP/GRPR signaling and astrocyte activation. Blocking GRP/GRPR with RC-3095 reduced pruritus in both UP and morphine-induced models, confirming LCN2's role in itch transmission.
Conclusion: LCN2 mediates pruritus by promoting GRP/GRPR signaling, astrocyte activation, and neuroinflammation, making it a potential therapeutic target for CKD-related and opioid-induced pruritus.
Keywords: Chemokine; GRP/GRPR; LCN2; Morphine-induced pruritus; Pro-inflammatory cytokine; Uremic pruritus.
© 2025. The Author(s), under exclusive licence to Japanese Society of Nephrology.
Conflict of interest statement
Declarations. Competing interest: No. Ethical approval: The human protocol was approved by the Joint Ethics Committee of the Ministry of Health under Approval No- HMU2024_789321 while animal protocol for both models were approved by Hebei Medical University under ethical approval HMU_2024-56990310. Consent to participate: Not applicable. Consent to publish: Not applicable.
Similar articles
-
Sensitization of spinal itch transmission neurons in a mouse model of chronic itch requires an astrocytic factor.J Allergy Clin Immunol. 2020 Jan;145(1):183-191.e10. doi: 10.1016/j.jaci.2019.09.034. Epub 2019 Nov 28. J Allergy Clin Immunol. 2020. PMID: 31787267
-
Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice.PLoS One. 2013 Jun 24;8(6):e67422. doi: 10.1371/journal.pone.0067422. Print 2013. PLoS One. 2013. PMID: 23826298 Free PMC article.
-
Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition.Brain. 2021 Mar 3;144(2):665-681. doi: 10.1093/brain/awaa430. Brain. 2021. PMID: 33367648
-
Gastrointestinal peptides and itch sensation.Curr Opin Endocrinol Diabetes Obes. 2015 Feb;22(1):29-33. doi: 10.1097/MED.0000000000000122. Curr Opin Endocrinol Diabetes Obes. 2015. PMID: 25485517 Review.
-
Itching, chloroquine, and malaria: a review of recent molecular and neuroscience advances and their contribution to mechanistic understanding and therapeutics of chronic non-histaminergic pruritus.Int J Dermatol. 2019 Aug;58(8):880-891. doi: 10.1111/ijd.14252. Epub 2018 Oct 26. Int J Dermatol. 2019. PMID: 30362504 Review.
References
-
- Almeras C, Argilés A. The general picture of uremia. Semin Dial. 2009;22(4):329–33. https://doi.org/10.1111/j.1525-139X.2009.00575.x . - DOI - PubMed
-
- Amaram-Davila J, Davis M, Reddy A. Opioids and cancer mortality. Curr Treat Options Oncol. 2020;21(3):22. https://doi.org/10.1007/s11864-020-0713-7 . - DOI - PubMed
-
- Barzegar H, Moosazadeh M, Jafari H, Esmaeili R. Evaluation of dialysis adequacy in hemodialysis patients: a systematic review. Urol J. 2016;13(4):2744–9. - PubMed
-
- Bazid HAS, Sakr HG, Abdallah RA, Arafat ES, Ragheb A, Seleit I. Serum and tissue lipocalin-2 expression in chronic kidney disease pruritic patients. Appl Immunohistochem Mol Morphol. 2023;31(9):635–43. https://doi.org/10.1097/pai.0000000000001151 . - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous